from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3208/-

LFCtreatmentdescriptionclass of inhibitor

-0.572

Amikacinug/mL Amikacintranslation

0.432

Cap5-10ug/mL Capreomycintranslation

0.170

Rox10-50 ug/mL Roxithromycintranslation

0.371

SM2-5 ug/mL Streptomycintranslation

-0.485

Tet5-10 ug/mL Tetracyclinetranslation

-2.458

Rif0.2-5ug/mL Rifampicintranscription

-0.705

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.644

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.475

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.951

CPZ10-50 ug/mL Chlorpromazinerespiration

0.329

Clofazimine10-13 ug/mL Clofaziminerespiration

0.516

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.073

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.105

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.629

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.102

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.158

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.682

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.989

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.011

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.813

KCN5-20 ug/mL Potassium cyaniderespiration

0.428

NaN30.2-2 mM Sodium aziderespiration

1.183

Nigericin50 uM Nigericinrespiration

-0.948

TRC10-150 ug/mL Triclosanrespiration

-0.936

TRZ10-25 ug/mL Thioridazinerespiration

0.519

Valinomycin0.5-10 uM Valinomycinrespiration

0.921

ZnSO42 mM ZnSO4respiration

1.166

menadione6-10 ug/mL Menadionerespiration

-0.479

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.287

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.663

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.734

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.122

NRP_1Non-replicating persistence stage 1dosRassociated

0.558

Amp0.2mg/mL AmpicillincellWall

0.244

Cephalexin20-100 ug/mL CephalexincellWall

0.424

Cerulenin0.32-5 ug/mL CerulenincellWall

0.182

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.068

EMB10-20 ug/mL EthambutolcellWall

0.824

Eta12-40 ug/mL EthionamidecellWall

0.929

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.203

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.175

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.902

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.703

BZA0.12 mg/mL BenzamidearomaticAmides

-0.544

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.121

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.059

H2O24 mM hydrogen peroxideDNAdamaging

-0.245

Levo10 ug/mL LevofloxacinDNAdamaging

-0.028

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.764

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.274

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.297

UVUV-irradiationDNAdamaging

-0.883

ARP41-4 ug/mL Antitubercular compound ARP4?

0.480

Antimycin12.5-50 ug/mL Antimycin A?

0.329

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.461

PA_110-50 ug/mL Antitubercular compound PA-1?

0.861

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.567

PA8240.2-2 ug/mL PA-824?

0.586

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.347

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.441

Verapamil50 uM Verapamil?

-0.028

mercaptoethanol2 mM 2-Mercaptoethanol?

0.101

methoxatin10-20 ug/mL Methoxatin?